• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Evolv Technology Reports Record Third Quarter Financial Results

    11/9/23 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology
    Get the next $EVLV alert in real time by email

    – Company Reaffirms Previously Raised Outlook for 2023 and Issues Outlook for 2024 Above Street Consensus –

    • Q3 Revenue of $20.2 million, up 22% year-over-year
    • Q3 Ending ARR1 of $65.8 million, up 129% year-over-year
    • Q3 Ending RPO2 of $221.1 million, up 102% year-over-year
    • Q3 Ending Evolv Express® subscriptions of 4,014, up 137% year-over-year

    Evolv Technology (NASDAQ:EVLV), the leader in AI-based weapons detection security screening, today announced financial results for the quarter ended September 30, 2023, reaffirmed its previously raised business outlook for 2023 and issued its preliminary outlook for 2024..

    Results for the Third Quarter of 2023

    Total revenue for the third quarter of 2023 was $20.2 million, an increase of 22% compared to $16.5 million for the third quarter of 2022. Annual Recurring Revenue ("ARR")1 was $65.8 million at the end of third quarter of 2023, an increase of 129% compared to $28.7 million at the end of the third quarter of 2022. Net income for the third quarter of 2023 was $6.0 million, or $0.04 per basic share and $0.03 per diluted share, compared to net loss of $(18.6) million, or $(0.13) per basic and diluted share, in the third quarter of 2022. Adjusted earnings (loss)3 for the third quarter of 2023 was $(12.0) million, or $(0.08) per diluted share, compared to adjusted earnings (loss)3 of $(18.6) million, or $(0.13) per diluted share, for the third quarter of 2022. Adjusted EBITDA3 for the third quarter of 2023 was $(11.1) million compared to $(18.0) million in the third quarter of 2022. As of September 30, 2023, the Company had cash, cash equivalents, marketable securities, and restricted cash of $140.4 million and no debt.

    Results for the First Nine Months of 2023

    Total revenue for the nine months ended September 30, 2023 was $58.6 million, an increase of 71% compared to $34.3 million for the nine months ended September 30, 2022. Net loss for the nine months ended September 30, 2023 was $(89.4) million, or $(0.60) per basic and diluted share, compared to net loss of $(58.1) million, or $(0.40) per basic and diluted share, in the nine months ended September 30, 2022. Adjusted earnings (loss)3 for the nine months ended September 30, 2023 was $(43.1) million, or $(0.29) per diluted share, compared to adjusted earnings (loss)3 of $(54.3) million, or $(0.38) per diluted share, for the nine months ended September 30, 2022. Adjusted EBITDA3 for the nine months ended September 30, 2023 was $(40.3) million compared to $(51.7) million in the nine months ended September 30, 2022.

    The following table summarizes the breakdown of recurring and non-recurring revenue4 during each quarter:

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

     

    % Change

     

    2023

     

    2022

     

    % Change

    Recurring revenue

    $

    14,377

     

    $

    6,221

     

    131

    %

     

    $

    35,141

     

    $

    13,984

     

    151

    %

    Non-recurring revenue

     

    5,814

     

     

    10,309

     

    (44

    )%

     

     

    23,456

     

     

    20,326

     

    15

    %

    Total revenue

    $

    20,191

     

    $

    16,530

     

    22

    %

     

    $

    58,597

     

    $

    34,310

     

    71

    %

    The following table summarizes operating cash flows during each quarter:

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

     

    2023

     

    2022

    Net income (loss)

    $

    5,999

     

     

    $

    (18,615

    )

     

    $

    (89,364

    )

     

    $

    (58,102

    )

    Non-cash (income) expense

     

    (16,446

    )

     

     

    1,771

     

     

     

    51,784

     

     

     

    4,403

     

    Changes in operating assets and liabilities

     

    12,544

     

     

     

    (82

    )

     

     

    30,922

     

     

     

    (15,722

    )

    Net cash provided by (used in) operating activities

    $

    2,097

     

     

    $

    (16,926

    )

     

    $

    (6,658

    )

     

    $

    (69,421

    )

    Company Provides Preliminary Outlook for 2024

    The Company today reaffirmed its business outlook for 2023 as previously raised on October 12, 2023 and provided a preliminary outlook for 2024. The Company's outlook is based on the current indications for its business, which may change at any time.

     

     

    2023 Business Outlook

     

    2024 Business Outlook

    Estimate ($ in millions)

     

    Raised October 12, 2023

     

    Issued November 9, 2023

     

    Issued November 9, 2023

    Total Revenue

     

    $75-$77

     

    Reaffirmed

     

    ~$115

    ARR1 (ARR) at 12/31/23

     

    $73-$75

     

    Reaffirmed

     

    $108-$112

    Adjusted Gross Margin3

     

    43%-45%

     

    Reaffirmed

     

    ~60%

    Adjusted EBITDA3

     

    ($50-$53)

     

    Reaffirmed

     

    Improve by 40%+

    Company to Host Live Conference Call and Webcast

    The Company's management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management's outlook for the business and other matters. The conference call may be accessed in the United States by dialing +1.877.692.8955 and using access code 825879. The conference call may be accessed outside of the United States by dialing +1.234.720.6979 and using the same access code. The conference call will be simultaneously webcast on the Company's investor relations website, which can be accessed at http://ir.evolvtechnology.com. A replay of the conference call will be available for a period of 30 days by dialing +1.866.207.1041 or +1.402.970.0847 and using access code 4536095 or by accessing the webcast replay on the Company's investor relations website at http://ir.evolvtechnology.com.

    About Evolv Technology

    Evolv Technology (NASDAQ:EVLV) is transforming human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered weapons detection and analytics. Its mission is to transform security to create a safer world to work, learn, and play. Evolv has digitally transformed the gateways in places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than 1 billion people, second only to the Department of Homeland Security's Transportation Security Administration (TSA) in the United States. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category. Evolv Technology®, Evolv Express®, Evolv Insights®, Evolv Cortex AI®, and Evolv Extend™ are registered trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.

    1 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

    2 We define Remaining Performance Obligation, or RPO, as estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied or partially satisfied as of the end of the quarter.

    3 Non-GAAP Financial Measures In this press release, the Company's adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude one-time items and stock-based compensation expense which management believes provides a more meaningful representation of contribution margin. Adjusted operating expenses is defined as operating expenses less one-time items, stock-based compensation expense, restructuring expenses, and loss on impairment of lease equipment which management believes provides a more meaningful representation of on-going operating expense levels. Adjusted EBITDA is defined as net income (loss) plus depreciation and amortization, share-based compensation, and certain other one-time expenses. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, change in fair value of derivative liability, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, change in fair value of common stock warrant liability, restructuring expenses, loss on impairment of lease equipment, and certain other one-time expenses. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted Gross Margin to GAAP Gross Margin and non-GAAP Adjusted EBITDA to Net Income (Loss), each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company's control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of derivative liabilities, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company's future financial results.

    4 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is one-time in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release other than statements of historical facts, including without limitation statements regarding our ability to meet our 2023 guidance for revenue, ARR, adjusted gross margin, and adjusted EBITDA, as well as our estimates for cash and cash equivalents for fiscal year 2023. Words such as "believe" "may," "will," "expect," "should," "could," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "project," "plan," "target," "is/are likely to" or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: expectations regarding the Company's strategies and future financial performance, including its future business plans or objectives, prospective performance, competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, and capital expenditures; the Company's history of losses and lack of profitability; the Company's reliance on third party contract manufacturing and a global supply chain; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the loss of designation of the Evolv Express system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; the ability for the Company to obtain, maintain, protect and enforce the Company's intellectual property rights and use of "open source" software; the concentration of the Company's revenues on a single solution; the Company's ability to timely design, produce and launch its solutions, the Company's ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company's securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; the impact of fluctuating general economic and market conditions; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources, and the Company's ability to identify and implement digital advances in its technology. These and other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission ("SEC") on March 24, 2023, as may be updated from time to time in other filings we make with the SEC including our Quarterly Report on Form 10-Q for the quarter ended on June 30, 2023 that was filed with the SEC on August 10, 2023, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release.

    These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue:

     

     

     

     

     

     

     

    Product revenue

    $

    3,191

     

     

    $

    9,839

     

     

    $

    19,188

     

     

    $

    19,179

     

    Subscription revenue

     

    10,231

     

     

     

    5,198

     

     

     

    24,661

     

     

     

    12,208

     

    Service revenue

     

    4,757

     

     

     

    1,493

     

     

     

    12,736

     

     

     

    2,923

     

    License fee and other revenue

     

    2,012

     

     

     

    —

     

     

     

    2,012

     

     

     

    —

     

    Total revenue

     

    20,191

     

     

     

    16,530

     

     

     

    58,597

     

     

     

    34,310

     

    Cost of revenue:

     

     

     

     

     

     

     

    Cost of product revenue

     

    3,153

     

     

     

    12,960

     

     

     

    21,453

     

     

     

    23,513

     

    Cost of subscription revenue

     

    4,231

     

     

     

    2,207

     

     

     

    9,988

     

     

     

    5,730

     

    Cost of service revenue

     

    1,417

     

     

     

    1,138

     

     

     

    3,588

     

     

     

    3,392

     

    Total cost of revenue

     

    8,801

     

     

     

    16,305

     

     

     

    35,029

     

     

     

    32,635

     

    Gross profit

     

    11,390

     

     

     

    225

     

     

     

    23,568

     

     

     

    1,675

     

    Operating expenses:

     

     

     

     

     

     

     

    Research and development

     

    6,409

     

     

     

    5,616

     

     

     

    18,193

     

     

     

    13,947

     

    Sales and marketing

     

    13,919

     

     

     

    11,746

     

     

     

    40,336

     

     

     

    33,169

     

    General and administrative

     

    11,273

     

     

     

    8,839

     

     

     

    31,073

     

     

     

    29,268

     

    Loss from impairment of property and equipment

     

    28

     

     

     

    626

     

     

     

    322

     

     

     

    1,038

     

    Total operating expenses

     

    31,629

     

     

     

    26,827

     

     

     

    89,924

     

     

     

    77,422

     

    Loss from operations

     

    (20,239

    )

     

     

    (26,602

    )

     

     

    (66,356

    )

     

     

    (75,747

    )

    Other income (expense), net:

     

     

     

     

     

     

     

    Interest expense

     

    —

     

     

     

    (188

    )

     

     

    (654

    )

     

     

    (489

    )

    Interest income

     

    1,791

     

     

     

    1,052

     

     

     

    4,597

     

     

     

    1,611

     

    Other expense, net

     

    (64

    )

     

     

    (57

    )

     

     

    (67

    )

     

     

    (57

    )

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    (626

    )

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    14,078

     

     

     

    7,245

     

     

     

    (17,353

    )

     

     

    9,754

     

    Change in fair value of contingently issuable common stock liability

     

    2,277

     

     

     

    1,081

     

     

     

    (3,560

    )

     

     

    2,529

     

    Change in fair value of public warrant liability

     

    8,156

     

     

     

    (1,146

    )

     

     

    (5,345

    )

     

     

    4,297

     

    Total other income (expense), net

     

    26,238

     

     

     

    7,987

     

     

    $

    (23,008

    )

     

    $

    17,645

     

    Net income (loss)

    $

    5,999

     

     

    $

    (18,615

    )

     

    $

    (89,364

    )

     

    $

    (58,102

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    150,206,893

     

     

     

    144,117,273

     

     

     

    148,521,299

     

     

     

    143,522,555

     

    Diluted

     

    173,976,375

     

     

     

    144,117,273

     

     

     

    148,521,299

     

     

     

    143,522,555

     

    Net income (loss) per share

     

     

     

     

     

     

     

    Basic

    $

    0.04

     

     

    $

    (0.13

    )

     

    $

    (0.60

    )

     

    $

    (0.40

    )

    Diluted

    $

    0.03

     

     

    $

    (0.13

    )

     

    $

    (0.60

    )

     

    $

    (0.40

    )

     

     

     

     

     

     

     

     

    Net income (loss)

    $

    5,999

     

     

    $

    (18,615

    )

     

    $

    (89,364

    )

     

    $

    (58,102

    )

    Other comprehensive income (loss)

     

     

     

     

     

     

     

    Cumulative translation adjustment

     

    34

     

     

     

    45

     

     

     

    1

     

     

     

    35

     

    Total other comprehensive income

     

    34

     

     

     

    45

     

     

     

    1

     

     

     

    35

     

    Total comprehensive income (loss)

    $

    6,033

     

     

    $

    (18,570

    )

     

    $

    (89,363

    )

     

    $

    (58,067

    )

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    September 30, 2023

     

    December 31, 2022

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    99,617

     

     

    $

    229,783

     

    Restricted cash

     

    1,000

     

     

     

    —

     

    Marketable securities

     

    39,487

     

     

     

    —

     

    Accounts receivable, net

     

    29,786

     

     

     

    31,920

     

    Inventory

     

    7,826

     

     

     

    10,257

     

    Current portion of contract assets

     

    3,667

     

     

     

    2,852

     

    Current portion of commission asset

     

    3,908

     

     

     

    3,384

     

    Prepaid expenses and other current assets

     

    16,500

     

     

     

    14,388

     

    Total current assets

     

    201,791

     

     

     

    292,584

     

    Restricted cash, noncurrent

     

    275

     

     

     

    275

     

    Contract assets, noncurrent

     

    496

     

     

     

    1,386

     

    Commission asset, noncurrent

     

    6,888

     

     

     

    5,655

     

    Property and equipment, net

     

    93,995

     

     

     

    44,707

     

    Operating lease right-of-use assets

     

    1,537

     

     

     

    1,673

     

    Other assets

     

    1,483

     

     

     

    1,835

     

    Total assets

    $

    306,465

     

     

    $

    348,115

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    13,887

     

     

    $

    18,194

     

    Accrued expenses and other current liabilities

     

    12,164

     

     

     

    11,545

     

    Current portion of deferred revenue

     

    53,041

     

     

     

    18,273

     

    Current portion of long-term debt

     

    —

     

     

     

    10,000

     

    Current portion of operating lease liabilities

     

    1,655

     

     

     

    1,114

     

    Total current liabilities

     

    80,747

     

     

     

    59,126

     

    Deferred revenue, noncurrent

     

    19,478

     

     

     

    17,695

     

    Long-term debt, noncurrent

     

    —

     

     

     

    19,683

     

    Operating lease liabilities, noncurrent

     

    133

     

     

     

    892

     

    Contingent earn-out liability

     

    31,571

     

     

     

    14,218

     

    Contingently issuable common stock liability

     

    6,952

     

     

     

    3,392

     

    Public warrant liability

     

    11,469

     

     

     

    6,124

     

    Total liabilities

     

    150,350

     

     

     

    121,130

     

     

     

     

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.0001 par value; 100,000,000 authorized at September 30, 2023 and December 31, 2022; no shares issued and outstanding at September 30, 2023 and December 31, 2022

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value; 1,100,000,000 shares authorized at September 30, 2023 and December 31, 2022; 150,661,124 and 145,204,974 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

     

    15

     

     

     

    15

     

    Additional paid-in capital

     

    437,683

     

     

     

    419,190

     

    Accumulated other comprehensive loss

     

    (9

    )

     

     

    (10

    )

    Accumulated deficit

     

    (281,574

    )

     

     

    (192,210

    )

    Stockholders' equity

     

    156,115

     

     

     

    226,985

     

    Total liabilities and stockholders' equity

    $

    306,465

     

     

    $

    348,115

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (89,364

    )

     

    $

    (58,102

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

    Depreciation and amortization

     

    6,781

     

     

     

    3,782

     

    Write-off of inventory and change in inventory reserve

     

    581

     

     

     

    559

     

    Adjustment to property and equipment for sales type leases

     

    —

     

     

     

    (625

    )

    Loss from impairment of property and equipment

     

    322

     

     

     

    1,038

     

    Stock-based compensation

     

    17,303

     

     

     

    15,513

     

    Non-cash interest expense

     

    22

     

     

     

    14

     

    Accretion of discount on marketable securities

     

    (482

    )

     

     

    —

     

    Non-cash lease expense

     

    136

     

     

     

    602

     

    Change in allowance for expected credit losses

     

    237

     

     

     

    100

     

    Loss on extinguishment of debt

     

    626

     

     

     

    —

     

    Change in fair value of earn-out liability

     

    17,353

     

     

     

    (9,754

    )

    Change in fair value of contingently issuable common stock

     

    3,560

     

     

     

    (2,529

    )

    Change in fair value of public warrant liability

     

    5,345

     

     

     

    (4,297

    )

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    2,107

     

     

     

    (14,822

    )

    Inventory

     

    2,041

     

     

     

    (4,401

    )

    Commission assets

     

    (1,757

    )

     

     

    (1,656

    )

    Contract assets

     

    75

     

     

     

    (1,938

    )

    Other assets

     

    352

     

     

     

    (629

    )

    Prepaid expenses and other current assets

     

    (2,111

    )

     

     

    (9,009

    )

    Accounts payable

     

    (6,396

    )

     

     

    2,177

     

    Deferred revenue

     

    36,551

     

     

     

    16,005

     

    Accrued expenses and other current liabilities

     

    278

     

     

     

    (750

    )

    Operating lease liability

     

    (218

    )

     

     

    (699

    )

    Net cash used in operating activities

     

    (6,658

    )

     

     

    (69,421

    )

    Cash flows from investing activities:

     

     

     

    Development of internal-use software

     

    (2,202

    )

     

     

    (1,936

    )

    Purchases of property and equipment

     

    (51,646

    )

     

     

    (17,554

    )

    Proceeds from sale of property and equipment

     

    60

     

     

     

    312

     

    Purchases of marketable securities

     

    (58,652

    )

     

     

    —

     

    Proceeds from maturities of marketable securities

     

    19,647

     

     

     

    —

     

    Net cash used in investing activities

     

    (92,793

    )

     

     

    (19,178

    )

    Cash flows from financing activities:

     

     

     

    Proceeds from exercise of stock options and warrants

     

    616

     

     

     

    571

     

    Proceeds from long-term debt

     

    1,876

     

     

     

    —

     

    Repayment of principal on long-term debt

     

    (31,876

    )

     

     

    (1,000

    )

    Payment of debt issuance costs and prepayment penalty

     

    (332

    )

     

     

    —

     

    Net cash provided by (used in) financing activities

     

    (29,716

    )

     

     

    (429

    )

    Effect of exchange rate changes on cash and cash equivalents

     

    1

     

     

     

    35

     

    Net increase (decrease) in cash, cash equivalents and restricted cash

     

    (129,166

    )

     

     

    (88,993

    )

    Cash, cash equivalents and restricted cash

     

     

     

    Cash, cash equivalents and restricted cash at beginning of period

     

    230,058

     

     

     

    308,167

     

    Cash, cash equivalents and restricted cash at end of period

    $

    100,892

     

     

    $

    219,174

     

    EVOLV TECHNOLOGY

    SUMMARY OF KEY OPERATING STATISTICS

    (Unaudited)

     

     

    Three Months Ended or as of,

    ($ in thousands)

     

    March 31,

    2022

     

    June 30,

    2022

     

    September 30,

    2022

     

    December 31,

    2022

     

    March 31,

    2023

     

    June 30,

    2023

     

    September 30,

    2023

    New customers

     

     

    44

     

     

    53

     

     

    92

     

     

    106

     

     

    61

     

     

    74

     

     

    70

    Annual recurring revenue

     

    $

    16,641

     

    $

    20,865

     

    $

    28,741

     

    $

    34,120

     

    $

    42,021

     

    $

    54,339

     

    $

    65,774

    Recurring revenue

     

    $

    3,159

     

    $

    4,604

     

    $

    6,221

     

    $

    7,388

     

    $

    9,075

     

    $

    11,689

     

    $

    14,377

    Remaining performance obligation

     

    $

    63,750

     

    $

    80,978

     

    $

    109,407

     

    $

    144,561

     

    $

    161,813

     

    $

    198,296

     

    $

    221,126

    Net additions

     

     

    207

     

     

    237

     

     

    545

     

     

    575

     

     

    520

     

     

    599

     

     

    628

    Ending deployed units

     

     

    910

     

     

    1,147

     

     

    1,692

     

     

    2,267

     

     

    2,787

     

     

    3,386

     

     

    4,014

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended,

     

     

    March 31,

    2022

     

    June 30,

    2022

     

    September 30,

    2022

     

    December 31,

    2022

     

    March 31,

    2023

     

    June 30,

    2023

     

    September 30,

    2023

    Operating expenses, GAAP

     

    $

    24,760

     

     

    $

    25,835

     

     

    $

    26,827

     

     

    $

    26,868

     

     

    $

    27,256

     

     

    $

    31,039

     

     

    $

    31,629

     

    Stock-based compensation

     

     

    (3,819

    )

     

     

    (4,781

    )

     

     

    (6,298

    )

     

     

    (6,771

    )

     

     

    (4,898

    )

     

     

    (6,505

    )

     

     

    (5,454

    )

    Restructuring expenses

     

     

    (324

    )

     

     

    13

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

    Loss on impairment of lease equipment

     

     

    (96

    )

     

     

    (316

    )

     

     

    (626

    )

     

     

    (123

    )

     

     

    (137

    )

     

     

    (157

    )

     

     

    (28

    )

    Other one-time expenses

     

     

    (1,107

    )

     

     

    (2,298

    )

     

     

    (69

    )

     

     

    (41

    )

     

     

    (53

    )

     

     

    (683

    )

     

     

    (945

    )

    Adjusted Operating Expenses

     

    $

    19,414

     

     

    $

    18,453

     

     

    $

    19,834

     

     

    $

    19,933

     

     

    $

    22,168

     

     

    $

    23,694

     

     

    $

    25,202

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP OPERATING INCOME (LOSS) TO ADJUSTED OPERATING INCOME (LOSS)

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

    $

    20,191

     

     

    $

    16,530

     

     

    $

    58,597

     

     

    $

    34,310

     

    Cost of Revenue

     

    8,801

     

     

     

    16,305

     

     

     

    35,029

     

     

     

    32,635

     

    Gross Profit, GAAP

     

    11,390

     

     

     

    225

     

     

     

    23,568

     

     

     

    1,675

     

    Stock-based compensation

     

    117

     

     

     

    227

     

     

     

    446

     

     

     

    615

     

    Amortization of capitalized stock-based compensation

     

    12

     

     

     

    6

     

     

     

    33

     

     

     

    15

     

    Adjusted Gross Profit

    $

    11,519

     

     

    $

    458

     

     

    $

    24,047

     

     

    $

    2,305

     

     

     

     

     

     

     

     

     

    Gross Margin %

     

    56.4

    %

     

     

    1.4

    %

     

     

    40.2

    %

     

     

    4.9

    %

    Adjusted Gross Margin %

     

    57.1

    %

     

     

    2.8

    %

     

     

    41.0

    %

     

     

    6.7

    %

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

     

    2023

     

    2022

    Operating income (loss), GAAP

    $

    (20,239

    )

     

    $

    (26,602

    )

     

    $

    (66,356

    )

     

    $

    (75,747

    )

    Stock-based compensation

     

    5,571

     

     

     

    6,525

     

     

     

    17,303

     

     

     

    15,513

     

    Amortization of capitalized stock-based compensation

     

    12

     

     

     

    6

     

     

     

    33

     

     

     

    15

     

    Restructuring expenses

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    311

     

    Loss on impairment of lease equipment

     

    28

     

     

     

    626

     

     

     

    322

     

     

     

    1,038

     

    Other one-time expenses

     

    945

     

     

     

    69

     

     

     

    1,681

     

     

     

    3,474

     

    Adjusted Operating Income (Loss)

    $

    (13,683

    )

     

    $

    (19,376

    )

     

    $

    (47,017

    )

     

    $

    (55,396

    )

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

     

    2023

     

    2022

    Net income (loss)

    $

    5,999

     

     

    $

    (18,615

    )

     

    $

    (89,364

    )

     

    $

    (58,102

    )

    Depreciation & amortization

     

    2,694

     

     

     

    1,432

     

     

     

    6,781

     

     

     

    3,782

     

    Stock-based compensation

     

    5,571

     

     

     

    6,525

     

     

     

    17,303

     

     

     

    15,513

     

    Interest expense (income)

     

    (1,791

    )

     

     

    (864

    )

     

     

    (3,943

    )

     

     

    (1,122

    )

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    626

     

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    (14,078

    )

     

     

    (7,245

    )

     

     

    17,353

     

     

     

    (9,754

    )

    Change in fair value of contingently issuable common stock liability

     

    (2,277

    )

     

     

    (1,081

    )

     

     

    3,560

     

     

     

    (2,529

    )

    Change in fair value of public warrant liability

     

    (8,156

    )

     

     

    1,146

     

     

     

    5,345

     

     

     

    (4,297

    )

    Restructuring expenses

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    311

     

    Loss on impairment of lease equipment

     

    28

     

     

     

    626

     

     

     

    322

     

     

     

    1,038

     

    Other one-time expenses

     

    945

     

     

     

    69

     

     

     

    1,681

     

     

     

    3,474

     

    Adjusted EBITDA

    $

    (11,065

    )

     

    $

    (18,007

    )

     

    $

    (40,336

    )

     

    $

    (51,686

    )

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2023

     

    2022

     

    2023

     

    2022

    Net income (loss)

    $

    5,999

     

     

    $

    (18,615

    )

     

    $

    (89,364

    )

     

    $

    (58,102

    )

    Stock-based compensation

     

    5,571

     

     

     

    6,525

     

     

     

    17,303

     

     

     

    15,513

     

    Amortization of capitalized stock-based compensation

     

    12

     

     

     

    6

     

     

     

    33

     

     

     

    15

     

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    626

     

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    (14,078

    )

     

     

    (7,245

    )

     

     

    17,353

     

     

     

    (9,754

    )

    Change in fair value of contingently issuable common stock liability

     

    (2,277

    )

     

     

    (1,081

    )

     

     

    3,560

     

     

     

    (2,529

    )

    Change in fair value of public warrant liability

     

    (8,156

    )

     

     

    1,146

     

     

     

    5,345

     

     

     

    (4,297

    )

    Restructuring expenses

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    311

     

    Loss on impairment of lease equipment

     

    28

     

     

     

    626

     

     

     

    322

     

     

     

    1,038

     

    Other one-time expenses

     

    945

     

     

     

    69

     

     

     

    1,681

     

     

     

    3,474

     

    Adjusted Earnings (Loss)

    $

    (11,956

    )

     

    $

    (18,569

    )

     

    $

    (43,141

    )

     

    $

    (54,331

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – diluted

     

    150,206,893

     

     

     

    144,117,273

     

     

     

    148,521,299

     

     

     

    143,522,555

     

     

     

     

     

     

     

     

     

    Adjusted Earnings (Loss) Per Share – diluted

    $

    (0.08

    )

     

    $

    (0.13

    )

     

    $

    (0.29

    )

     

    $

    (0.38

    )

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231109348574/en/

    Get the next $EVLV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EVLV

    DatePrice TargetRatingAnalyst
    10/28/2024Outperform → Market Perform
    Northland Capital
    5/20/2024$8.50 → $5.75Buy
    Craig Hallum
    5/10/2024$6.00 → $3.50Buy → Hold
    Lake Street
    11/21/2023$6.00Buy
    Lake Street
    4/28/2023$6.00Buy
    Craig Hallum
    2/8/2023$5.40Overweight
    Cantor Fitzgerald
    3/15/2022$10.00 → $2.00Buy → Hold
    Stifel
    8/26/2021$12.00Buy
    Stifel
    More analyst ratings

    $EVLV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Evolv Technology to Present at Cowen Technology Conference

      Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced its scheduled participation in the Cowen Technology Conference on Thursday, May 29, 2025 in New York, New York. Presenting on behalf of the Company will be Mr. John Kedzierski, the Company's President and Chief Executive Officer and Mr. Chris Kutsor, the Company's Chief Financial Officer. Additional details including a link to the associated webcast will be available at the Company's investor relations website at https://ir.evolvtechnology.com. About Evolv Technology Evolv Technology (NASDAQ:EVLV) is designed to transform

      5/8/25 4:05:00 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Rahway Public Schools Deploys Evolv Technology to Enhance Student Safety

      Rahway Public Schools adopts Evolv Express® and Evolv eXpedite™ to strengthen entryway safety Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced its partnership with Rahway Public Schools in Rahway, NJ. The district recently installed Evolv Express® and Evolv eXpedite™ systems at its gymnasium and performing arts entrances, marking a significant step forward in school security. The combination of Express and eXpedite will allow students to be screened without having to take laptops out of their bags. "Our top priority is the safety and well-being of our staff, students,

      5/8/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technology to Release First Quarter Financial Results on May 20, 2025

      Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the first quarter of 2025 on Tuesday, May 20, 2025, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv Technologies Holdings, Inc (NASDAQ:EVLV) is designed to transform human security to make a safer, f

      5/7/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Evolv Technologies Holdings downgraded by Northland Capital

      Northland Capital downgraded Evolv Technologies Holdings from Outperform to Market Perform

      10/28/24 8:56:54 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Craig Hallum resumed coverage on Evolv Technologies Holdings with a new price target

      Craig Hallum resumed coverage of Evolv Technologies Holdings with a rating of Buy and set a new price target of $5.75 from $8.50 previously

      5/20/24 8:37:06 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technologies Holdings downgraded by Lake Street with a new price target

      Lake Street downgraded Evolv Technologies Holdings from Buy to Hold and set a new price target of $3.50 from $6.00 previously

      5/10/24 7:57:29 AM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Evolv Technologies Holdings Inc.

      DEFA14A - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

      4/30/25 4:16:08 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • SEC Form DEF 14A filed by Evolv Technologies Holdings Inc.

      DEF 14A - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

      4/30/25 4:14:42 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • SEC Form 10-K filed by Evolv Technologies Holdings Inc.

      10-K - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

      4/28/25 5:04:33 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Glat Neil bought $24,999 worth of shares (8,333 units at $3.00), increasing direct ownership by 5% to 162,355 units (SEC Form 4)

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      8/14/24 4:05:45 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Director Gonzales David Mounts bought $150,000 worth of shares (50,000 units at $3.00), increasing direct ownership by 71% to 120,544 units (SEC Form 4)

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      8/14/24 4:05:10 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Gonzales David Mounts bought $193,000 worth of shares (50,000 units at $3.86) (SEC Form 4)

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      3/7/24 5:32:10 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

      SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

      12/12/24 3:21:41 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

      SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

      11/12/24 2:31:40 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

      SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

      11/7/24 4:31:46 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Financials

    Live finance-specific insights

    See more
    • Evolv Technology to Release First Quarter Financial Results on May 20, 2025

      Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the first quarter of 2025 on Tuesday, May 20, 2025, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv Technologies Holdings, Inc (NASDAQ:EVLV) is designed to transform human security to make a safer, f

      5/7/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technology Announces Receipt of Extension from Nasdaq Stock Market

      Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) (the "Company" or "Evolv Technology"), a leading security technology company pioneering AI-powered solutions designed to create safer experiences, today announced that on January 31, 2025, it received a letter from the Nasdaq Stock Market ("Nasdaq") informing the Company that Nasdaq has granted the Company's request for an exception to Nasdaq's Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The exception gives the Company until May 19, 2025 to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Quarterl

      2/3/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technology Provides Business Update

      – Company Reaffirms Outlook for Positive Adjusted EBITDA1 by Q2 2025 – – Company Provides Update on Restatement Effort and Regulatory Inquiry – Evolv Technology, Inc. (NASDAQ:EVLV) (the "Company"), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today provided an update on select strategic metrics for the three-month period ended December 31, 20242. The Company also provided an update on its pending restatement effort and other regulatory matters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250123179310/en/ According to preliminary estimates which are subject to ch

      1/23/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Leadership Updates

    Live Leadership Updates

    See more
    • Evolv Technology Appoints Chris Kutsor as Chief Financial Officer

      –Evolv Welcomes Proven High-Tech Public Company CFO as Company Enters New Stage of Growth– Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced the appointment of Mr. Chris Kutsor as Chief Financial Officer. The appointment will be effective one business day following the filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423812661/en/Chris Kutsor, Chief Financial Officer "We are thrilled to welcome Chris to our le

      4/23/25 8:00:00 AM ET
      $EVLV
      $MSI
      Computer peripheral equipment
      Technology
      Radio And Television Broadcasting And Communications Equipment
    • Partnership with Cosm Reinforces Evolv Technology's Sports Industry Position as Innovation Leader

      Evolv brings advanced fan-friendly screening experience to Cosm's initial sites in Los Angeles and Dallas Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it recently entered a partnership with Cosm, the immersive entertainment company pioneering news ways to experience sports and entertainment content. The partnership brings Evolv's advanced Express® systems to Cosm's first two locations, in the Los Angeles and Dallas metro areas. Express will be used to help deliver the secure, fast, and convenient entry screening process at the Cosm sites for major events that p

      4/16/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • San Francisco Giants Deploy Latest Evolv Express® Gen2 Systems for 2025 Season

      Oracle Park upgrades Evolv Express systems initially deployed in 2021 to a new fleet, becoming the first professional sports team to renew its four-year subscription Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced an extended and expanded relationship with the San Francisco Giants. Under the new agreement, which will see Evolv designated as a Proud Partner of the team, the existing fleet of 20 Evolv Express security systems will be swapped for Evolv's latest Gen2 units offering enhanced mobility and easier deployment. Evolv Express systems have been used to screen

      4/10/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Financial Officer Kutsor George C

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      5/5/25 5:00:11 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • SEC Form 3 filed by new insider Kutsor George C

      3 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      5/5/25 4:59:34 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • SEC Form 4 filed by Director Sullivan Mark J.

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      3/5/25 4:09:18 PM ET
      $EVLV
      Computer peripheral equipment
      Technology